NCT05741775 Physiotherapy Intervention for Migraine Symptoms
| NCT ID | NCT05741775 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Universiti Tunku Abdul Rahman |
| Condition | Migraine |
| Study Type | INTERVENTIONAL |
| Enrollment | 87 participants |
| Start Date | 2022-09-18 |
| Primary Completion | 2024-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 87 participants in total. It began in 2022-09-18 with a primary completion date of 2024-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this randomized control trial is to analyse the effectiveness of Physiotherapy intervention among university students with migraine symptoms. The main objective is: 1. To determine the effect of aerobic exercise on the resting-state brainwaves among university students in UTAR with migraine symptoms compared with biofeedback and control exercise. 2. To analyse the influence of aerobic exercise on the sleep quality and quality of life among the cohort compared with biofeedback and control exercise. Although the Migraine Research Foundation listed three main types of non-drug treatments for migraine are lifestyle advice, therapies, and exercises. Some common aerobic exercises such as walking, jogging, a behavioral weight loss program, cycling, and a combination of cross-training, walking, jogging, and cycling are suggested to be beneficial to the migraine patients but there remains no specific protocol established till now. Hence the other main objective of this is to establish a aerobic exercise protocol for patients with migraine symptoms.
Eligibility Criteria
Inclusion Criteria: * Undergraduate, and postgraduate students from Universiti Tunku Abdul Rahman * 4 of 5 on the Migraine Screen Questionnaire Exclusion Criteria: * Score of more than or equal to 5 on the visual aura rating scale, * Diagnosed to have a secondary headache (headache attributed to the causative disorder example: infection, trauma, injury to head/ or neck) * Pregnancy, * Took medication for neurological conditions like stroke, multiple sclerosis and took medications for cardiorespiratory conditions like asthma, * Took medications for headache and * Unwilling to participate will be excluded
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05741775 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Migraine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT05741775 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 87 participants.
Is NCT05741775 currently recruiting?
Yes, NCT05741775 is actively recruiting participants. Contact the research team at kiruthika@utar.edu.my for enrollment information.
Where is the NCT05741775 trial being conducted?
This trial is being conducted at Kajang, Malaysia.
Who is sponsoring the NCT05741775 clinical trial?
NCT05741775 is sponsored by Universiti Tunku Abdul Rahman. The trial plans to enroll 87 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.